Francesca Puggioni, MD, explains how real-world registry data, like the EU-ADVANTAGE study, informs regulatory decisions on ...

VHA/CMS screening identified 11,809 veterans with PV; after exclusions, 5,287 and 5,245 were analyzed for mortality and ...

In "Inside the Be Well Trials: Design, Population, and Patient Selection," the panel walks through why the Be Well trials ...

In "Cross-Trial Vitiligo Data: What Payers Can and Can't Compare," the panel compares cross-trial data directly and discusses ...

This episode, "How Bepirovirsen Targets the Hepatitis B Viral Lifecycle," features the panel debating how much of this ...

Ifosfamide shortages affect 94% of centers, with notable constraints also reported for carboplatin, cisplatin, BCG, and ...

Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...

Jorgen Vestbo, MD, on the COPERNICOS trial results, long-term antibiotic use versus resistance concerns, and where COPD treatment is headed. The COPERNICOS (NCT04481555) trial, a multicenter, ...

Policy changes could have the greatest impact on transplant equity, explains hematologic oncologist Karilyn Larkin, MD. Clinical trials and transplantation remain critical components of care for ...

The share of children aged 8 to 11 years with obesity who were prescribed glucagon-like peptide-1 (GLP-1) receptor agonists rose 310-fold between January 2019 and June 2026, even though absolute use ...

New Harris Poll data show mental health, access, and postpartum care gaps persist for US mothers, with Black and Hispanic women hit hardest.

Francesca Puggioni, MD, discusses real-world exacerbations, biomarker-driven access, and barriers to earlier biologic use in asthma and COPD. Panel discussions and abstract presentations at the ...